Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Ispaghula husk [gastro-intestinal bulk laxative] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Ispaghula husk 3.4g/sachet s/f powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Ispaghula husk 6g/sachet s/f powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Ispaghula husk lemon/lime 3.4g/sachet s/f powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Ispaghula husk orange 3.4g/sachet s/f powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Ispaghula husk orange 3.5g/sachet s/f granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Ispaghula husk lemon 3.5g/sachet s/f granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Ispaghula husk 3.5g/sachet s/f granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Ispaghula husk 56% powder 6.4g |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Ispaghula husk [lipid lowering use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Ispaghula husk orange 3.5g s/f granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Ispaghula husk powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Ispaghula husk granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Product containing ispaghula husk (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ispaghula husk (substance) |
Inferred relationship |
Some |
1 |
Ispaghula husk agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Ispaghula husk 3.5g/sachet s/f powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Ispaghula husk 3.5g effervescent granules sachets gluten free sugar free |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Senna+ispaghula 12.4%/54.2% granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Product containing psyllium and senna (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Ispaghula husk 3.5g/sachet s/f powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Product containing ispaghula husk and mebeverine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ispaghula husk (substance) |
Inferred relationship |
Some |
1 |
Ispaghula husk 3.4g/sachet conventional release oral powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Ispaghula husk 3.5g/sachet conventional release oral powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Ispaghula husk 3.5g/sachet granules |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ispaghula husk (substance) |
Inferred relationship |
Some |
|
Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ispaghula husk (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ispaghula husk (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ispaghula husk 3.5 gram/1 sachet granules for conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ispaghula husk (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ispaghula husk 3.5 gram/1 sachet granules for conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ispaghula husk (substance) |
Inferred relationship |
Some |
1 |
Ispaghula husk 6 g powder for oral suspension sachet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ispaghula husk (substance) |
Inferred relationship |
Some |
1 |
Ispaghula husk 6 g powder for oral suspension sachet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ispaghula husk (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ispaghula husk (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ispaghula husk (substance) |
Inferred relationship |
Some |
1 |
Product containing ispaghula husk and mebeverine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ispaghula husk (substance) |
Inferred relationship |
Some |
1 |
Ispaghula husk-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ispaghula husk (substance) |
Inferred relationship |
Some |
1 |
Product containing only ispaghula husk (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ispaghula husk (substance) |
Inferred relationship |
Some |
1 |
Ispaghula husk and mebeverine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ispaghula husk (substance) |
Inferred relationship |
Some |
1 |
Ispaghula husk and mebeverine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ispaghula husk (substance) |
Inferred relationship |
Some |
1 |
Product containing only ispaghula husk in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ispaghula husk (substance) |
Inferred relationship |
Some |
1 |